Good morning :)
$
₹
Electromed Inc

Electromed Inc

ELMD

AMEX
Asset Logo

Electromed Inc

ELMD

AMEX
$26.590.86% (+0.22)
$
₹
$26.590.86% (+0.22)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Micro Cap

With a market cap of $218.5M the stock is ranked 4113

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

20.28
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.79
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.3
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.35
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

15.32%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 3 analysts reports

Buy
3 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+83.92%

Earnings Growth

+11.3%

Rev. Growth

+12.71%

See Detailed Forecast

Company Profile

Company Profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
38.55
38.55
1Y Return
18.86%
18.86%
Buy Reco %
85.71
85.71
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.16
38.16
1Y Return
3.48%
3.48%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
54.69
54.69
1Y Return
17.95%
17.95%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
23.44
23.44
1Y Return
1.27%
1.27%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
31.82
31.82
1Y Return
19.81%
19.81%
Buy Reco %
79.31
79.31
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 83.92% growth, versus a trailing 3-year CAGR of 36.80%.

2026
Current$26.37Baseline
Analyst Target - 1 year
Target$48.5+83.92%

All values in $

202220232024202520262027$20.42$31.40$42.37Target+83.92%
2026
Current$26.37Baseline
Analyst Target - 1 year
Target$48.5+83.92%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 12.71% growth, versus a trailing 3-year CAGR of 15.35%.

2026
Current$73.77Baseline
Forecast for Jun 2027
High$83.8+13.59%
Average$83.15+12.71%
Low$82.5+11.82%

All values in $ Million

20222023202420252026202741.6548.0654.716473.77Low+11.82%Average+12.71%High+13.59%
2026
Current$73.77Baseline
Forecast for Jun 2027
High$83.8+13.59%
Average$83.15+12.71%
Low$82.5+11.82%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 11.30% growth, versus a trailing 3-year CAGR of 53.71%.

2026
Current$1.31Baseline
Forecast for Jun 2027
High$1.53+17.04%
Average$1.46+11.3%
Low$1.38+5.56%

All values in $

2022202320242025202620270.260.360.580.841.31Low+5.56%Average+11.3%High+17.04%
2026
Current$1.31Baseline
Forecast for Jun 2027
High$1.53+17.04%
Average$1.46+11.3%
Low$1.38+5.56%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

16.8
2.1
18.8
2.7
18.5
3
19.4
3.4
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue13.8714.8314.6616.2515.6817.3916.8818.8918.5719.41
Net Income1.491.821.471.961.892.202.132.7633.40
Net Profit Margin10.76%12.32%10.04%12.10%12.05%12.67%12.64%14.61%16.16%17.51%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Electromed Inc 20.284.790.35
Abbott Laboratories38.553.572.12
Danaher Corporation38.162.951.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare ELMD with any stock or ETF
Compare ELMD with any stock or ETF
Comparing from
ELMD
ABT
DHR
Loading...

Frequently asked questions

  1. Electromed Inc (ELMD) share price today is $26.59 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $27.27 and a day low of $26.30.

  2. Electromed Inc stock trades on AMEX under the ticker symbol ELMD.

  3. Electromed Inc's market capitalization is $218.53M as of October 27, 2026 at 1:29 AM IST.

  4. Electromed Inc's price-to-earnings (P/E) ratio is 20.28 as of October 26, 2026.

  5. Electromed Inc's price-to-book (P/B) ratio is 4.79 as of October 26, 2026.

  6. Yes, You can buy Electromed Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Electromed Inc shares in three steps: 1. Search Electromed Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Electromed Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Electromed Inc (ELMD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3759 shares at the current price of $26.59.

Loading...